Founded in 2022 in Germany by Elçin Can Çavuşoğlu, Baturay Yalvaç and Yalvaç Top, Breathment provides at-home digital therapeutic solutions for chronic respiratory diseases including COPD and asthma. The platform delivers personalized treatment to patients while promising cost savings for insurers. Using a patent-pending AI technology, Breathment offers a mobile, 24/7 digital physiotherapist experience accessible via patients' smartphones. The solution also enables remote monitoring and data-driven interventions for healthcare professionals. In a clinical study in Germany, Breathment demonstrated a 21.4% reduction in symptoms among COPD patients and a 20% improvement in overall health level. The company is reimbursed by leading insurers in Germany and Switzerland and aims to use the investment to further develop its health technology and accelerate growth across Europe.

Total raised

$1M

Funding rounds

1

Latest round

Seed

Latest activity

Aug 2025